Cellular-level analysis disclosed significantly higher GPD1L levels in non-malignant NCM460 cells compared to CRC lines (HCT116/DLD-1/SW480: P<0.01; SW620: P<0.05, Figure 2b). The gene discussed is GPD1L; the disease is colorectal carcinoma.